AGIO:NASDAQ
Agios Pharmaceuticals Inc
၂၉.၈၉ US$
arrow_downward
-၀.၈၆%(-၀.၂၆) 1D
၂၉.၈၉ US$
၀.၀၀% (၀.၀၀)
bedtimeAfter hours
Closed: နို ၁၇, GMT-၅ ၁၆:၀၀:၀၁ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for AGIO...
Open
၃၀.၀၉ US$
High
၃၀.၃၈ US$
Low
၂၈.၉၄ US$
Mkt. cap
၁၇၈.၇၇ ဋေ
Avg. vol.
၁.၂၃ သန်း
Volume
၆.၆၅ သိန်း
52-wk high
၄၅.၉၉ US$
52-wk low
၂၂.၂၄ US$
EPS
-၆.၃၂ US$
Beta
၀.၆၆
Shares outstanding
၅.၉၈ ကုဋေ
No. of employees
၅၄၀
Open
၃၀.၀၉ US$
High
၃၀.၃၈ US$
Low
၂၈.၉၄ US$
Mkt. cap
၁၇၈.၇၇ ဋေ
Avg. vol.
၁.၂၃ သန်း
Volume
၆.၆၅ သိန်း
52-wk high
၄၅.၉၉ US$
52-wk low
၂၂.၂၄ US$
EPS
-၆.၃၂ US$
Beta
၀.၆၆
Shares outstanding
၅.၉၈ ကုဋေ
No. of employees
၅၄၀
News stories
From web sources and news partners
TradingView
·
ပြီးခဲ့သည့် ၄ နာရီ
S&P 500, Dow, Nasdaq Futures Power Ahead On Nvidia Outlook Beat — NVDA, TSLA, ANT In Focus
BigGo Finance
·
ပြီးခဲ့သည့် ၆ နာရီ
Wall Street Split on 2027 S&P 500 Outlook: Wells Fargo's 8,200 vs. Morgan Stanley's 8,700
ChartMill
·
ပြီးခဲ့သည့် ၆ နာရီ
S&P 500 After-Hours Gainers for Nov. 17, 2026
Traders Union
·
ပြီးခဲ့သည့် ၃ နာရီ
S&P 500 rises 10 percent amid challenging backdrop, Nate Geraci notes
Profile
Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013. Wikipedia
About Agios Pharmaceuticals Inc